Does TRIPTORELIN Cause Injection site mass? 10 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Injection site mass have been filed in association with TRIPTORELIN (TRIPTODUR). This represents 0.2% of all adverse event reports for TRIPTORELIN.
10
Reports of Injection site mass with TRIPTORELIN
0.2%
of all TRIPTORELIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Injection site mass From TRIPTORELIN?
Of the 10 reports, 4 (40.0%) required hospitalization.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIPTORELIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does TRIPTORELIN Cause?
Off label use (545)
Death (362)
Ovarian hyperstimulation syndrome (356)
Needle issue (242)
Disease progression (203)
Product dose omission issue (178)
Drug ineffective (175)
Weight increased (167)
Hot flush (153)
Headache (145)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which TRIPTORELIN Alternatives Have Lower Injection site mass Risk?
TRIPTORELIN vs TRISODIUM
TRIPTORELIN vs TROFINETIDE
TRIPTORELIN vs TROFOSFAMIDE
TRIPTORELIN vs TROPATEPINE
TRIPTORELIN vs TROPICAMIDE